ストックスクリーナーアプリを入手
5.00
2.53%
-0.13
Alvotech (ALVO) 最新ニュース
Alvotech Raises USD 100 Million Term Loan to Bolster Biosimilar Growth and 2026 Launches - TipRanks
Alvotech’s Volatile Ascent: Can A High?Beta Biosimilar Pure Play Keep Its Momentum? - AD HOC NEWS
Alvotech secures $100 million loan facility - Biostock
Icelandic BioTech Alvotech secures €100 million term loan facility to bolster liquidity and R&D investment - EU-Startups
What analysts say about Alvotech Z45 stockEarnings Forecast Updates & Double Digit Returns - earlytimes.in
Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in US - MSN
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged ... - Bluefield Daily Telegraph
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Alvotech Secures USD 100 Million Senior Term Loan to Enhance Liquidity and Support R&D Initiatives - Quiver Quantitative
Alvotech Secures Term Loan Facility of USD 100 Million - The Manila Times
Alvotech (NASDAQ:ALVO) Trading 2.9% HigherShould You Buy? - MarketBeat
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - PR Newswire
Alvotech announced that it has received $100 million in funding - marketscreener.com
The Technical Signals Behind (ALVO) That Institutions Follow - Stock Traders Daily
ALVO Investor News: If You Have Suffered Losses in Alvotech - GlobeNewswire
Alvotech Files Notification with CSSF Regarding Changes in Own Shares - Quiver Quantitative
Changes in company's own shares - marketscreener.com
Alvotech : Changes in company's own shares - marketscreener.com
Alvotech : Acquisition or disposal of the issuer's own sharesALVOTECH - marketscreener.com
EV Market: Why Alvotech stock is favored by top institutionsMarket Sentiment Review & Growth Oriented Trading Recommendations - moha.gov.vn
Mereo BioPharma, Ultragenyx Pharmaceutical And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why Bolt Projects Holdings Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Benzinga
Alvotech (NASDAQ:ALVO) Short Interest Down 41.1% in December - MarketBeat
Is Alvotech stock near bottom after declineSwing Trading Watchlist & Build Wealth Brick by Brick With Us - bollywoodhelpline.com
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Inves - GuruFocus
Alvotech (NASDAQ:ALVO) Trading Up 6.8%Time to Buy? - MarketBeat
Alvotech (ALVO): Firm reaffirms 2025 growth outlook - MSN
Alvotech Begins European Rollout of First-Ever Simponi Biosimilar Gobivaz - TipRanks
Why Alvotech (ALVO) Is Down 8.5% After Securing a 2026 US Entry Window for AVT06 - simplywall.st
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma - Sahm
Alvotech announces European launch of biosimilar to Simponi - MSN
Alvotech/Advanz First to Launch Golimumab Biosimilar Worldwide - Pearce IP
Alvotech’s Financial Calendar for 2026 - The Manila Times
Alvotech : Financial Calendar for 2026 - marketscreener.com
Alvotech rolls out first Simponi biosimilar across Europe - The Pharma Letter
Alvotech Launching Gobivaz Biosimilar in Europe - marketscreener.com
New Simponi lookalike drug rolls out in Europe with NHS backing - Stock Titan
Alvotech Announces Launch of Gobivaz® (AVT05) in the UK Following NHS England Tender Award - Quiver Quantitative
Alvotech, Teva reach settlement and license agreement with Regeneron for AVT06 - MSN
Fund Flows: Is Alvotech stock supported by strong fundamentalsMarket Risk Analysis & Real-Time Volume Analysis Alerts - moha.gov.vn
Alvotech (ALVO): Firm Reaffirms 2025 Growth Outlook - Finviz
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - ACCESS Newswire
Assessing Alvotech (NasdaqGM:ALVO)’s Valuation After FDA Setback and 2025 Guidance Cut - simplywall.st
Big Money Moves: Why retail investors favor Alvotech stockEarnings Miss & Short-Term Trading Opportunity Alerts - ulpravda.ru
Volume Recap: Why Alvotech Equity Warrant stock remains resilient2025 Market WrapUp & Long Hold Capital Preservation Tips - ulpravda.ru
Alvotech, Teva secure US settlement with Regeneron for Eylea biosimilar launch - Indian Pharma Post
Can Alvotech stock beat market expectations this quarterMarket Activity Recap & Capital Efficient Trading Techniques - ulpravda.ru
Is Alvotech stock gaining market shareJuly 2025 Macro Moves & Community Trade Idea Sharing Platform - ulpravda.ru
Alvotech to raise $100M via convertible bonds, provides 2026 forecast - MSN
Alvotech price target lowered to $10 from $14 at Morgan Stanley - MSN
How interest rate cuts could boost Alvotech Equity Warrant stockQuarterly Trade Summary & Free Reliable Trade Execution Plans - ulpravda.ru
Can Alvotech stock sustain revenue growthRecession Risk & Stock Portfolio Risk Management - ulpravda.ru
Dip Buying: Is Alvotech stock near bottom after decline2025 Retail Activity & Technical Buy Zone Confirmation - Улправда
Partners Alvotech, Teva eye 2026 Eylea biosimilar launch in US with Regeneron settlement - Fierce Pharma
2.71%
0.84%
大文字化:
|
ボリューム (24 時間):